WASHINGTON–(BUSINESS WIRE)–Optica, The Optical Society’s newest journal, dedicated to rapidly disseminating the highest impact peer-reviewed research across the entire spectrum of optics and photonics, has celebrated its one-year anniversary. In its first year, Optica has established itself as a trusted source for some of the best and most exciting work in the optics and photonics field, demonstrated by 45% growth in article downloads in 2015 so far and 1 in 6 articles being featured in mains
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Abbie Celniker, CEO of Eleven Biotherapeutics, will present at the NewsMakers in the Biotech Industry Conference ion Thursday, September 10, 2015 at 3:30 pm ET.
ALAMEDA, Calif.–(BUSINESS WIRE)–InSite Vision Inc. (OTCBB: INSV) today announced that InSite and QLT Inc. (NASDAQ: QLTI) (TSX: QLT) entered into a revised merger agreement under which QLT will acquire InSite Vision. Under the terms of the revised mer…
WASHINGTON–(BUSINESS WIRE)–To promote the progress and promise of light research and education, leading U.S. science organizations will host two events on Saturday, September 12, 2015, in Washington. The events are organized by the National Science Foundation (NSF) in conjunction with The American Institute of Physics, The American Physical Society, The IEEE Photonics Society, The National Academy of Sciences, The Optical Society and the International Society for Optics and Photonics (SPIE).
SEATTLE–(BUSINESS WIRE)–Acucela Inc. (TOKYO: 4589) (“Acucela” or the “Company”), a clinical-stage biotechnology company that specializes in discovering and developing novel drug candidates to potentially treat and slow the progression of sight-threatening ophthalmic diseases, announced today that it has hired Dr. George Lasezkay as Executive Vice President, Legal Affairs, effective Aug. 24. Dr. Lasezkay will head up Acucela’s legal team and be the primary legal advisor to CEO Ryo Kubota and t
BARCELONA, Spain–(BUSINESS WIRE)–Glaukos Technologies Featured in Nine Podium and Poster Presentations at 2015 ESCRS
CARLSBAD, Calif.–(BUSINESS WIRE)–Heidelberg Engineering has entered into a patent license agreement with Massachusetts General Hospital (MGH) in Boston. The agreement grants global and exclusive rights to 77 basic patents and patent applications whic…
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay Pharmaceuticals’ intelli-Case featured on ABC7 in San Francisco Bay Area.
PLEASANTON, Calif.–(BUSINESS WIRE)–The revolutionary RapidHIT® System from IntegenX delivered a stunning arrest in the UK last week. A suspect was arrested for a minor crime and swabbed for a DNA reference sample while in custody. His DNA profile was generated in less than two hours using the RapidHIT System at UK forensic laboratory, Key Forensic Services. Upon upload to the UK’s National DNA Database® (NDNAD), the suspect’s profile immediately matched with a DNA profile recovered from a ser
ALAMEDA, Calif.–(BUSINESS WIRE)–InSite Vision Inc. (OTCBB:INSV) today announced that InSite’s Board of Directors determined that the previously announced unsolicited offer from a multi-national pharmaceutical company (the “Bidder”) to acquire InSite for $0.25 per share in an all-cash transaction constitutes a “Company Superior Proposal” as defined in InSite’s previously announced definitive agreement with QLT Inc. dated as of June 8, 2015, as amended (NASDAQ: QLTI) (TSX: QLT). Under the terms
PLEASANTON, Calif.–(BUSINESS WIRE)–Clarity Medical Systems, Inc. announced today the hiring of several new key members of its Executive Leadership Team. These executives will initially focus on the commercial introduction of Clarity’s upcoming product, HOLOS IntraOP™, a continuous real-time intraoperative aberrometer for refractive cataract surgery. Clarity is a leader in the development, manufacturing, and marketing of integrated optical systems and services that enhance the clinician’s abil
LEXINGTON, Mass.–(BUSINESS WIRE)–ITEK Announces completion of $79 million offering
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/t595n6/dry_atrophic) has announced the addition of the “Dry (Atrophic) Macular Degeneration-Pipeline Insights” report to their offering. Summary Dry (Atrophic) Ma…
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company commercializing and developing topical non-antibiotic antimicrobial products for the global eye care market, today reported financial results for the three months and six months ended June 30, 2015, and provided a business update. Quarterly and Recent Operational and Financial Highlights Grew sales of Avenova™ Lid and Lash Cleanser by 73% to $806,000 in the second quarter of 2015 ove
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Eleven Biotherapeutics Reports Second Quarter 2015 Financial Results. Management to host conference call today at 8:30 a.m. ET.
LEXINGTON, Mass.–(BUSINESS WIRE)–Inotek Pharmaceuticals Corporation prices $68.9 million public offering
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Glaukos Corporations Announces Second Quarter 2015 Financial Results
ALAMEDA, Calif.–(BUSINESS WIRE)–InSite Vision Announces Date for Special Stockholder Meeting
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced financial results for the second quarter ended June 30, 2015. “We continued to make strong progress in our development programs this quarter and look forward to several significant clinical milestones expected during the second half of 2015. For our lead product candid